Nurix Therapeutics, Inc. revenue breakdown overview

Nurix Therapeutics, Inc. revenue for the last year amounted to 54.55 M USD, the most of which — 54.55 M USD — came from its highest performing source at the moment, Small Molecule and Cell Therapies, the year earlier bringing 76.99 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Nurix Therapeutics, Inc. 54.55 M USD, and the year before that — 76.99 M USD.